Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ELUTIA INC. shareholders approved Approval of the Aziyo Biologics, Inc. Amended and Restated 2020 Incentive Award Plan. at the 2023-06-08 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-08
Exact text from the filing
Item 3 – Approval of the Aziyo Biologics, Inc. Amended and Restated 2020 Incentive Award Plan. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 8,304,112 530,087 3,550 1,283,168
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ELUTIA INC. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. at the 2023-06-08 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-08
Exact text from the filing
Item 2 – Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 10,119,179 449 1,289 –
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ELUTIA INC. shareholders approved Election of two Class III directors to serve until the Company’s annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. at the 2023-06-08 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-08
Exact text from the filing
Item 1 – Election of two Class III directors to serve until the Company’s annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. Votes FOR Votes WITHHELD Broker Non-Votes David Colpman 8,611,885 225,864 1,283,168 Kevin Rakin 8,325,108 512,641 1,283,168
View on SEC.gov